1.Buchacz, K et al. (2008) Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994–2005. AIDS (London, England) 22, 1345–1354.
2.Gebo, KA, Diener-West, M and Moore, RD (2001) Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 27, 143–152.
3.Palella, FJ Jr et al. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New England Journal of Medicine 338, 853–860.
4.Paul, S et al. (2002) Impact of antiretroviral therapy on decreasing hospitalization rates of HIV-infected patients in 2001. AIDS Research Human Retroviruses 18, 501–506.
5.Volberding, PA and Deeks, SG (2010) Antiretroviral therapy and management of HIV infection. Lancet 376, 49–62.
6.Mocroft, A et al. (2000) Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. Royal Free Centre for HIV Medicine. AIDS (London, England) 14, 1545–1552.
7.Mocroft, A et al. (2003) Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 362, 22–29.
8.Crum-Cianflone, NF et al. (2010) Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use? Journal of Acquired Immune Deficiency Syndromes 54, 248–257.
9.Falster, K et al. (2010) Hospitalizations in a cohort of HIV patients in Australia, 1999–2007. AIDS (London, England) 24, 1329–1339.
10.Marin, B et al. (2009) Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. AIDS (London, England) 23, 1743–1753.
11.Mocroft, A et al. (2004) Changes in hospital admissions across Europe: 1995–2003. Results from the EuroSIDA study. HIV Medicine 5, 437–447.
12.Lin, DY (1994) Cox regression analysis of multivariate failure time data: the marginal approach. Statistics in Medicine 13, 2233–2247.
13.Driver, JA et al. (2008) Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study. BMJ 337, a2467.
14.Nasi, M et al. (2017) Ageing and inflammation in patients with HIV infection. Clinical and Experimental Immunology 187, 44–52.
15.Catumbela, E et al. (2015) HIV disease burden, cost, and length of stay in Portuguese hospitals from 2000 to 2010: a cross-sectional study. BMC Health Services Research 15, 144.
16.Coelho, LE et al. (2017) Hospitalization rates, length of stay and in-hospital mortality in a cohort of HIV infected patients from Rio de Janeiro, Brazil. Brazilian Journal of Infectious Diseases 21, 190–195.
17.Crowell, TA et al. (2015) Hospitalization rates and reasons among HIV elite controllers and persons with medically controlled HIV infection. Journal of Infectious Diseases 211, 1692–1702.
18.Lazar, R et al. (2017) Hospitalization rates among people with HIV/AIDS in New York city, 2013. Clinical Infectious Diseases 65, 469–476.
19.Mahlab-Guri, K et al. (2017) Hospitalizations of HIV patients in a major Israeli HIV/AIDS center during the years 2000 to 2012. Medicine (Baltimore) 96, e6812.
20.Oramasionwu, CU et al. (2014) National trends in hospitalization and mortality rates for patients with HIV, HCV, or HIV/HCV coinfection from 1996–2010 in the United States: a cross-sectional study. BMC Infectious Diseases 14, 536.
21.Tai, M, Liu, T and Merchant, RC (2015) Hospitalizations in the United States among HIV-infected individuals in short-stay hospitals, 1982 to 2010. Journal of the International Association of Providers of AIDS Care 14, 408–414.
22.Smit, M et al. (2016) Quantifying the future clinical burden of an ageing HIV positive population in Italy: a mathematical modelling study. Abstracts of the International Congress of Drug Therapy in HIV Infection 23–26 October 2016, Glasgow, UK. Abstract P156. In.